OGMBT Banner AM18 940x285 2

Overview

 

Celebrate life sciences with us

It is a great pleasure for us to welcome you to the 11th ÖGMBT Annual Meeting “Inside the World of Biomolecules” from September 16th - 18th, 2019 in Salzburg, Austria at the Wyndham Grand Conference Center.
The ÖGMBT Annual Meeting is the largest life science meeting in Austria and connects established scientists, early-career scientists with students and corporate representatives. See below for highlights of the 2019 meeting:

  • Scientists from all research areas welcome, as additional poster sessions with open topics will be held in addition to the main topics listed below
  • Meeting officially opened with the Life Science Awards Austria, the brightest young minds present their winning research efforts in form of the Research Award and PhD Award
  • Expand your horizons: three days of interdisciplinary scientific exchange with fellow scientists in Austria
  • Face-to-face meetings are increasingly important in our digitalized society – many cooperations have already blossomed after interacting at past Annual Meetings
  • Establish new career networks, discuss unpublished data or find out about early-stage endeavours that aren’t advertised online
  • Opportunities to connect are supported by official events like the popular “Wine & Science”, where all attendees are invited by exhibitors to enjoy wine and cheese (prime biotech products, of course) in an informal atmosphere
  • Joint Doctoral Schools: Science Meets Technology” session, PhD students from all “Doktoratskollegs” in Austria are welcome to present their work
  • Session “Trends in Development and Manufacturing in Biologics” as innovation platform for pharma companies, biotechs and academic researchers, featuring the development and production of new product

The organizing committee is looking forward to seeing you in Salzburg!

Silja Weßler, Gernot Posselt, Gerhard Obermeyer, Fritz Aberger, Günther Lepperdinger, Jutta Horejs-Hoeck, Bianca Chichirau and Alexandra Khassidov


Who should attend?

*Bachelor/Master students*

  • In three days, get an extensive overview of the Austrian life sciences scene
  • Meet key players of the scene and make invaluable new personal contacts in academia and industry
  • Find your next exciting project and interact with colleagues from diverse life science disciplines
  • Insights about opportunities, both in- and outside of the academic world

*PhD/Postdocs*

  • Tailor-made activities for young scientists at ÖGMBT YLSA satellites
  • Career Corner with Job Wall
  • CV-check on site by an industry professional
  • Submit an abstract for a chance to win one of the prestigious best poster or best talk awards

*Group Leaders/Professors*

  • Establish new cooperations, especially as new Group Leader
  • Refreshing insights on new techniques and experiments from different life science disciplines
  • Your next PhD/Postdoc could be among the attendees of the event

*Industry*

  • High-quality contacts with academic researchers for new cooperations
  • Draw attention to your company as significant player / employer / innovative product- / service provider in the field
  • Submit scientific abstracts as participant or present your company as exhibitor
  • Support the network by booking a sponsorship package
  • Find new buyers for your products and keep in contact with the existing ones


 

Main Topics

Translational oncology

Immune oncology

Immunology and allergology

Plant signaling

Tissue regeneration and cell based therapies

Trends in development and manufacturing of biologics

Microbial interactions and microbiome

Epigenetics

Infection biology

Joint doctoral schools: science meets technology

 

 

Invited Speakers

Leila Akkari
Netherlands Cancer Institute, NL

Francesco Boccellato
Max Planck Institute for Infection Biology, DE

Guido Boehmelt
Boehringer Ingelheim RCV GmbH & Co KG, AT

Daniel De Carvalho
UHN, CA

Massimo Dominici
Unimore, IT

Claudio Francesci (Plenary)
University of Bologna, IT

Peter Hegemann (Plenary)
Humboldt-University Berlin, DE

Frits Koning
Leiden University, NL

Markus Künzler
ETH Zürich, CH

Alberto Mantovani (Plenary)
Humanitas University, IT

Kim Midwood
University of Oxford, UK

Kevin Ryan
University of Glasgow, UK

Waltraud Schulze
University of Hohenheim, DE

Wolfram Weckwerth (Plenary)
University of Vienna, AT

 

Scientific Committee

Gernot Posselt
University of Salzburg

Gerhard Obermeyer
University of Salzburg

Fritz Aberger
University of Salzburg

Günther Lepperdinger
University of Salzburg

Jutta Horejs-Hoeck
University of Salzburg

Silja Weßler
University of Salzburg

Michael Sauer,
University of Natural Resources and Life Sciences

Bianca Chichirau
University of Salzburg

Martha Gschwandtner
University of Oxford

Roland Geisberger
SALK


Nadja Zaborsky 
SALK

Fatima Ferreira
Universty of Salzburg

Cornelia Kasper
University of Natural Resources and Life Sciences

Klaus Graumann
Phoenestra GmbH       

Susanne Zeilinger
Universty of Innsbruck

Kalina Duszka
University of Vienna

Evgenia Korotchenko
University of Salzburg      

Angela Risch
University of Salzburg

Andreas Weinhäusl  
AIT

 

Organizing Committee

Silja Weßler (Chair)
University of Salzburg

Günther Lepperdinger
University of Salzburg

Gernot Posselt
University of Salzburg

Jutta Horejs-Hoeck
University of Salzburg

Gerhard Obermeyer
University of Salzburg

Bianca Chichirau
YLSA / University of Salzburg

Fritz Aberger
University of Salzburg

Alexandra Khassidov
ÖGMBT

 

Venue

Wyndham Grand Salzburg Conference Centre
Fanny-von-Lehnert-Straße 7
5020 Salzburg

Guido Boehmelt, Boehringer Ingelheim RCV GmbH & Co KG, AT

Guido Boehmelt

Guido Boehmelt is Director of External Innovation in the globally acting Boehringer Ingelheim “Research Beyond Borders” (RBB) division. He received his PhD from the University of Vienna in 1993 following studies in Biology in Regensburg, Heidelberg and at the Research Institute of Molecular Pathology (IMP) in Vienna. His postdoctoral studies led him to the Ontario Cancer Institute/Princess Margaret Hospital and later to the Amgen Research Institute in Toronto, Canada. His main research interests in these years focused on understanding leukemia development and normal hematopoietic differentiation cues. In 1999 he joined the Boehringer Ingelheim Oncology unit in Biberach, Germany as laboratory head, and was Director of Target- and Lead Discovery, Oncology of Boehringer Ingelheim in Vienna from 2004-2013. Since then he led various external collaborations with universities, biotech companies and public-private consortia for Boehringer Ingelheim as Director Research Networking. Since 2016 he is heading RBB Austria in the identification, evaluation and implementation of innovative therapeutic approaches and technologies for Boehringer Ingelheim´s existing and future therapeutic areas.

Markus Künzler, ETH Zürich, CH

Markus Künzler

Markus Künzler is Adjunct Professor of Mycology at ETH Zürich and studies the molecular defense mechanisms of fungi towards bacterial and animal antagonists.

Markus graduated with a MSc in Natural Sciences at ETH Zürich in 1989 and completed his education with a PhD at the Department of Natural Sciences of ETH Zürich with Prof. Ralf Hütter/PD Dr. Gerhard Braus on the transcriptional regulation of aromatic amino acid biosynthesis in the yeast Saccharomyces cerevisiae in 1994. He received postdoctoral training at the Department of Molecular and Cell Biology of UC Berkeley (Laboratory of Prof. Jeremy Thorner) and at the Biochemie-Zentrum of Ruprecht-Karls-University Heidelberg (Laboratory of Prof. Ed Hurt) on the role of RanGTP-binding proteins in nucleocytoplasmic transport in S. cerevisiae from 1994 to 2001. From 2001 to 2017, Markus established, as Senior Scientist in the laboratory of Prof. Markus Aebi at the Department of Biology of ETH Zürich, a research group on molecular defense mechanisms of fungi (with main focus on the basidiomycetous mushroom Coprinopsis cinerea) towards bacterial and animal antagonists. In 2018, he was appointed Adjunct Professor of Mycology at ETH Zürich. He is member of the directory board of the Institute of Microbiology of ETH Zürich and actively involved in teaching Microbiology and Mycology at the Department of Biology. Markus is the main organizer of the annual Zürich Mycology Symposium and active member of the Mycology section of the Swiss Society of Microbiology. He was awarded the Silver medal of ETH Zürich für his MSc thesis, a EMBO and a HFSPO Long-Term Postdoctoral Fellowship and a SNSF Advanced Researcher Fellowship. He is author of numerous publications in prestigious journals and several patents.

Alberto Mantovani, Istituto Clinico Humanitas, Humanitas University, IT

Alberto Mantovani

Alberto Mantovani, MD, is Professor of Pathology at the Humanitas University in Milan, and Scientific Director of the Istituto Clinico Humanitas.  His attention has been focused on molecular mechanisms of innate immunity and inflammation. He has contributed to the advancement of knowledge in the field of Immunology formulating new paradigms and identifying new molecules and functions.

For his research activity he has received several national and international awards, such as the Triennial OECI Award from the Organization of the European Cancer Institutes,  the Robert Koch Award for his contribution to tumor immunology and immunotherapy, the American-Italian Cancer Foundation (AICF) Prize for Excellence in Medicine and, most recent, the American Association for Cancer Research International Pezcoller Award for Extraordinary Achievement in Cancer Research.The broad impact of his contributions is testified by citations.  As of January 2019 he has over 111,000 (Scopus), 80,000 (Web of Science) or 160,000 (Google Scholar) citations and an H-index of 161 (Scopus), 125 (Web of Science) or 185 (Google Scholar).   

Kim Midwood, University of Oxford, GB

Kim Midwood

Kim Midwood is Professor of Matrix Biology at Oxford University, and Principal Investigator at the Kennedy Institute of Rheumatology, studying how the cellular microenvironment drives, and shapes, immune responses.  

Kim graduated with a B.Sc. (HONS) in Biochemistry from Edinburgh University in 1995, and completed her Ph.D. in the Department of Pathology at Edinburgh University in 1999, identifying how changes in the extracellular matrix switch cell signalling pathways in arthritis. She undertook postdoctoral training in the Department of Molecular Biology at Princeton University in the US from 1999, investigating the molecular mechanisms by which environmental cues define cell phenotype.  In 2004 she established the Matrix Immunology group in the Kennedy Institute of Rheumatology at Imperial College London to examine how immunomodulatory matrix molecules contribute to healthy innate immune responses, and their role in pathological inflammation, moving to Oxford University in 2011.  In 2007 she was awarded an MRC New Investigators Award and in 2012 an Arthritis Research UK Senior Fellowship.  She founded the BioTech company Nascient Ltd in 2012

 

Kevin Ryan, Cancer Research UK Beatson Institute, GB

Kevin Ryan

Professor Kevin Ryan, FRSE, Senior Group Leader, Cancer Research UK Beatson Institute

Professor Kevin Ryan obtained a BSc from the University of Liverpool and a PhD from the University of Glasgow.  Following post-doctoral work at the US National Cancer Institute, he was awarded a CRUK Senior Fellowship and established a research group at the CRUK Beatson Institute.  In 2007 he became Senior Group Leader at the Beatson and later that year was appointed Professor of Molecular Cell Biology at the University of Glasgow.   Kevin’s studies focus on understanding how tumour cells regulate apoptosis and autophagy during tumour development and cancer therapy.  He has received several awards for his work including the EACR ‘Cancer Researcher Award’ and the 2012 Tenovus Medal.  Kevin is a Fellow of the Royal Society of Edinburgh.

Wolfram Weckwerth, University of Vienna, AT

Wolfram Weckwerth

Wolfram Weckwerth integrates system-theoretical ideas with genome-scale molecular analysis using genomics, transcriptomics, proteomics, phosphoproteomics and metabolomics to understand and predict the genotype - phenotype-relationship. He investigates plant, microbial, animal and human systems. Working in the field of metabolomics since 2000, Wolfram Weckwerth has established metabolomics, proteomics and phosphoproteomics platforms in Germany and Austria. In 2008 he moved as a full professor to the University of Vienna and founded the Department of Molecular Systems Biology (MOSYS). In 2013 he became founding chair of the newly structured Department of Ecogenomics and Systems Biology comprising a full PANOMICS platform and applications in green systems biology and agroecology. Since 2015 Wolfram Weckwerth is founding chair of the Vienna Metabolomics Center (VIME) (https://vime.at/). VIME has a focus on biomedical research questions and algorithms for data processing and integration, machine learning and biochemical interpretation, structural elucidation of unknown metabolites as well as metabolomics/life sciences databases. Wolfram Weckwerth published more than 200 publications on systems biology applications, multiomics analysis and data-driven inverse modelling, edited several books and is special chief editor of Frontiers Metabolomics.

Sponsors & Exhibitors

  • OEGTERM

  • AxonLab 440x252

  • 01 Berthold Logo 2019

  • logo sarstedt 440x252

  • LOGO BioCat 440x252

  • FEMS Master Logo Web 110x63

  • eurofins110

  • 02 MIC Logo Austria OrangeGrey RGB 440x252

  • Biozym110x63

  • S-Metr INULA GmbH 600

  • Lexogen Logo plus Claim

  • biomedica 110x63

  • Logo greiner bioone 2c RGB dcf2d90b f755 4fa2 b7f0 6293b149abd7

  • Takara 440x252

  • Szabo Scandic Logo 4C 110x63

  • NEB GmbH with inspired claim square 4c 4

  • EPPENDORF 110x63

  • logo mp bleu HQ CMJNtrans

     

     

     

  • licor logo blue

  • 1 pol

  • biolab

  • thp logo11265

  • STEMCELL 440x252

  • MERCK VIB M CELL SgRpVm 4C weiß

  • Logo PL

  • Cell Signaling 440x252

  • Stadt Salzburg 440x252

  • Essebio sartorius 440x252

  • Springer 440x252

next prev